Abstract:Oral delivery of insulin has the potential to revolutionize diabetes care since it is regarded as a noninvasive therapeutic approach without the side effects caused by frequent subcutaneous injection. However, the insulin delivery efficiency through oral route was still limited, likely due to the chemical, enzymatic and absorption barriers. In this study, a novel type of pH- and amylase-responsive microgels as an insulin drug carrier for oral administration was developed to improve the drug delivery efficiency. The microgels were prepared via aqueous dispersion copolymerization of acrylategrafted-carboxymethyl starch (CMS-g-AA) and 2-isobutyl-acrylic acid (iBAA). The resulting hybrid microgels with the PiBAA contents of 13.6-45.3 wt% exhibited sharp pH-sensitivity, which was revealed by the changes in particle size of the microgels and the transmittance of the microgel aqueous solution. The accelerated decomposition of the CMS-containing microgels in response to amylase was demonstrated by chromogenic reaction and morphology change. Insulin was loaded into the microgels by swelling-diffusion method, and the insulin release from the insulin-loaded microgels in vitro was found to be triggered by pH change and addition of amylase, which was highly dependent on the microgel component. Cytotoxicity assay was performed to show the good biocompatibility of the microgels. In addition, the tests of cellular uptake by Caco-2 cells and transmembrane transport through the Caco-2 cell monolayers were carried out to confirm the intestinal absorption ability of the insulin-loaded microgels. Finally, the oral administration of insulin-loaded microgels to STZ-induced diabetic rats led to a continuous decline in the fasting blood glucose level within 2 to 4 h, and the hypoglycemic effect maintained over 6 h in vivo. The relative pharmacological availability of the insulin-loaded microgels was enhanced 23-38 times compared to free-form insulin solution through oral route. Therefore, the novel starch-based microgels may have potential as an efficient platform for oral insulin delivery.

beta-Cyclodextrin-conjugated amino poly(glycerol methacrylate)s for efficient insulin delivery

β-Cyclodextrin-conjugated amino poly(glycerol methacrylate)s for efficient insulin delivery

Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin.

Amphiphilic QP(DMAEMA-co-LMA)-b-POEGMA Random-Block Terpolymers As Nanocarriers for Insulin

Glucose-Responsive Complex Micelles for Self-Regulated Release of Insulin under Physiological Conditions

Glucose-Sensitive Polyphosphoester Diblock Copolymer for an Insulin Delivery System

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

Glucose-Sensitive Polypeptide Micelles for Self-Regulated Insulin Release at Physiological Ph

Synthesis and Evaluation of a Novel Β-Cyclodextrin Derivative for Oral Insulin Delivery and Absorption

Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.

PEGylated insulin loaded complexation hydrogels for protected oral delivery

Dually-crosslinked Degradable Polyionic Micelles for Sustained Glucose-responsive Insulin Release

Phenylboronate-diol Crosslinked Glycopolymeric Nanocarriers for Insulin Delivery at Physiological Ph.

Ph- and Amylase-Responsive Carboxymethyl Starch/Poly(2-isobutyl-acrylic Acid) Hybrid Microgels As Effective Enteric Carriers for Oral Insulin Delivery

Well-defined degradable brush-coil block copolymers for intelligent release of insulin at physiological pH

Novel Amino-Β-cyclodextrins Containing Polymers: Fabrication, Characterization, and Biological Evaluation.

Glucose-responsive vehicles containing phenylborate ester for controlled insulin release at neutral pH.

Nitrilotriacetic Acid-Functionalized Glucose-Responsive Complex Micelles for the Efficient Encapsulation and Self-Regulated Release of Insulin

A Stimuli-Responsive Insulin Delivery System Based on Reversible Phenylboronate Modified Cyclodextrin with Glucose Triggered Host-Guest Interaction.

Ph- And Glucose-Sensitive Glycopolymer Nanoparticles Based On Phenylboronic Acid For Triggered Release Of Insulin

Glucose and H2O2 Dual-Responsive Polymeric Micelles for the Self-Regulated Release of Insulin.